In today’s healthcare system, data is playing an increasingly important role in modern medicines. With huge amounts of data available for AI, data-driven medicine has the potential to correct biases present in traditional medicine. Machine learning and automated assistance will become integral to successful healthcare enterprises. This will range from documentation and diagnostic support to personalized medication and treatment recommendations (e.g., for cancer care), imaging interpretation, and even friendly explanations of complex medical information. As AI evolves, it will play a role in all these areas.
Data-Driven Medicine
As AI and large data analysis advance, we are moving beyond the current hypothesis-testing model, which is susceptible to bias, toward a new paradigm. All a machine – learning algorithm needs to do is examining existing data; the accuracy and use of the algorithm depends upon the data it has been trained on. It is not biased in any way. In order to create predictions, it looks for patterns in data that already exists. Seeing the connections between various types of data objects is the foundation of machine learning. Associations that are only descriptive of the experiences recorded in the data arise when the data objects are medical elements and an enormous volumes of data are processed. Pattern searching can be broadly categorized into two approaches: surveys and drill-downs. Survey algorithms scan data for significant anomalies or signals without pre-existing hypotheses. Upon identifying a potential signal, a drill-down analysis can then investigate a specific question (e.g., the link between proton pump inhibitors like omeprazole and heart disease). Data-driven medicine analyses past data to improve real-time decisions and inform predictions. This approach allows for the assessment of all variables relevant to an individual, leading to personalized recommendations that are more precise than those derived from population-based studies. Predicting rare adverse drug reactions in specific individuals is a challenge for traditional evidence-based medicine. A data-driven approach, however, could potentially answer questions like: For this patient, with these specific genetic markers, lab results, and medical history, is she the rare individual who will develop Achilles tendon problems, even rupture, from levofloxacin for a kidney infection? Can this risk be known before prescribing? In situations where there is currently no data, prospective studies may be used to test novel treatment choices (drugs, other interventions), but daily medical practice will become more and more data-driven in the coming times.
Conclusion
Evidence-based medicine, which researchers conduct using prospective studies over extended periods, serves as the cornerstone of clinical medicine despite its susceptibility to various biases. Now that we are gathering vast amounts of data for AI algorithms to learn from and uncover connections between medical data items that have not been previously observed, data-driven medicine can help us overcome these possible biases. Data-driven medicine analyzes existing data to identify patterns, but it also eliminates the cognitive bases that arise when people make assumptions. This approach will evolve into the real-time precise method that practitioners use in daily medicine. This represents a significant paradigm shift in how we approach medical research and may become the driving force behind the future of customized, individualized medicine.
Read Whitepaper AI: A Smart Prescription for Evidence-Based Medicine
